Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
NCT ID:
NCT00055666
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Clinically or pathologically confirmed graft-versus-host disease of the gastrointestinal tract
* Failed standard therapy with or has a contraindication to systemic immunosuppressive agents
* No clinically significant intestinal infection (confirmed by stool culture)
* No persistent vomiting of all oral intake
* Not a candidate for approved beclomethasone dipropionate Enteron Pharmaceuticals protocol
PATIENT CHARACTERISTICS:
Age
* 4 to 70
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* Able to swallow medication
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* Not specified
Endocrine therapy
* See Disease Characteristics
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
70 Years
Study:
NCT00055666
Study Brief:
Protocol Section:
NCT00055666